Annexon Market Capitalization from 2010 to 2024
| ANNX Stock | USD 5.10 0.04 0.78% |
Check Annexon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annexon's main balance sheet or income statement drivers, such as Interest Expense of 4.4 M, Selling General Administrative of 19.2 M or Interest Income of 10.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0117 or PTB Ratio of 1.37. Annexon financial statements analysis is a perfect complement when working with Annexon Valuation or Volatility modules.
Annexon | Market Capitalization |
Latest Annexon's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Annexon over the last few years. It is Annexon's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annexon's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 547.89 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Annexon Market Capitalization Regression Statistics
| Arithmetic Mean | 552,221,006 | |
| Geometric Mean | 519,506,165 | |
| Coefficient Of Variation | 31.22 | |
| Mean Deviation | 151,904,730 | |
| Median | 678,808,281 | |
| Standard Deviation | 172,421,459 | |
| Sample Variance | 29729.2T | |
| Range | 475.4M | |
| R-Value | (0.70) | |
| Mean Square Error | 16235.5T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (27,067,858) | |
| Total Sum of Squares | 416208.2T |
Annexon Market Capitalization History
About Annexon Financial Statements
Annexon investors use historical fundamental indicators, such as Annexon's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Annexon. Please read more on our technical analysis and fundamental analysis pages.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company was incorporated in 2011 and is headquartered in Brisbane, California. Annexon operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Annexon Stock Analysis
When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.